MIRAE ASSET
LARGE CAP FUND - (MALCF)

(Large Cap Fund - An open ended equity scheme predominantly investing across large cap stocks)
Details as on March 31, 2023
Type of Scheme
Large Cap Fund - An open ended equity scheme predominantly investing across large cap stocks
Investment Objective
The investment objective of the scheme is to generate long term capital appreciation by capitalizing on potential investment opportunities by predominantly investing in equities of large cap companies. The Scheme does not guarantee or assure any returns.
Fund Managers**
Mr. Gaurav Misra (since January 31, 2019), and
Mr. Gaurav Khandelwal (since October 18, 2021)
Allotment Date
04th April, 2008
Benchmark Index
NIFTY 100 Index (TRI)
Minimum Investment
Amount
₹ 5,000/- and in multiples of ₹ 1/-thereafter. Minimum Additional Application Amount: ₹1,000/- per application and in multiples of ₹ 1/- thereafter.
Systematic Investment
Plan (SIP)
(Any Date SIP is available from 1st July, 2019)
Monthly and Quarterly: Minimum of ₹ 1000/- (multiples of ₹ 1/- thereafter), minimum 5 in case of Monthly or 3 in case of Quarterly option.
Load Structure
Entry load: NA
Exit load:
I. For investors who have opted for SWP under the plan:
a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil.
b) Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: (Redemption of units would be done on First In First Out Basis (FIFO):
•If redeemed within 1 year (365 days) from the date of allotment: 1%
•If redeemed after 1 year (365 days) from the date of allotment: NIL
II. Other Redemptions: For Investors who have not opted for SWP under the plan (including Switch out, STP out):
•If redeemed within 1 year (365 days) from the date of allotment: 1%
•If redeemed after 1 year (365 days) from the date of allotment: NIL
Plans Available
Regular Plan and Direct Plan
Options Available
Growth Option and IDCW Option (Payout & Re-investment)
Monthly Average AUM (₹ Cr.) as on March 31, 2023
32,705.41
Net AUM (₹ Cr.)
32,851.08
Monthly Avg. Expense Ratio
(Including Statutory Levies)
as on March 31, 2023
Regular Plan: 1.53%
Direct Plan: 0.46%
**For experience of Fund Managers Click Here
NAV: Direct Regular
Growth ₹ 84.474 ₹ 76.652
IDCW ₹ 52.028 ₹ 23.139
New Position Bought
Stock
Banks
Bank of Baroda
Finance
Bajaj Finserv Limited
Positions Increased
Stock
Auto Components
Sona BLW Precision Forgings Limited
Banks
Axis Bank Limited
Consumer Durables
Titan Company Limited
Ferrous Metals
Tata Steel Limited
Finance
Housing Development Finance Corporation Limited
IT - Software
HCL Technologies Limited
Infosys Limited
Petroleum Products
Reliance Industries Limited
Pharmaceuticals & Biotechnology
Biocon Limited
Sun Pharmaceutical Industries Limited
Retailing
FSN E-Commerce Ventures Limited
Positions Decreased
Stock
Automobiles
TVS Motor Company Limited
Banks
ICICI Bank Limited
Construction
Larsen & Toubro Limited
Consumer Durables
Voltas Limited
Diversified FMCG
Hindustan Unilever Limited
Finance
Muthoot Finance Limited
Petroleum Products
Hindustan Petroleum Corporation Limited
Pharmaceuticals & Biotechnology
Ajanta Pharma Limited
Dr. Reddy's Laboratories Limited
Power
NTPC Limited

Portfolio Holdings % Allocation
Banks
HDFC Bank Ltd
11.05%
ICICI Bank Ltd
9.19%
Axis Bank Ltd
4.99%
State Bank of India
3.23%
Kotak Mahindra Bank Ltd
0.41%
Bank of Baroda
0.36%
IT - Software
Infosys Ltd
7.10%
Tata Consultancy Services Ltd
2.38%
HCL Technologies Ltd
2.28%
MphasiS Ltd
0.51%
Petroleum Products
Reliance Industries Ltd
8.10%
Hindustan Petroleum Corporation Ltd
0.43%
Finance
Housing Development Finance Corporation Ltd
3.29%
SBI Cards and Payment Services Ltd
1.50%
Muthoot Finance Ltd
0.70%
Bajaj Finserv Ltd
0.09%
Consumer Durables
Titan Company Ltd
1.49%
Kajaria Ceramics Ltd
1.14%
Havells India Ltd
1.08%
Crompton Greaves Consumer Electricals Ltd
1.02%
Voltas Ltd
0.60%
Asian Paints Ltd
0.01%
Diversified FMCG
Hindustan Unilever Ltd
2.70%
ITC Ltd
2.19%
Pharmaceuticals & Biotechnology
Sun Pharmaceutical Industries Ltd
2.47%
Gland Pharma Ltd
0.76%
Torrent Pharmaceuticals Ltd
0.54%
Biocon Ltd
0.45%
Ajanta Pharma Ltd
0.24%
Divi's Laboratories Ltd
0.01%
Dr. Reddy's Laboratories Ltd
0.01%
Automobiles
Maruti Suzuki India Ltd
2.75%
Eicher Motors Ltd
0.64%
TVS Motor Company Ltd
0.44%
Telecom - Services
Bharti Airtel Ltd
3.65%
Construction
Larsen & Toubro Ltd
3.05%
Insurance
Max Financial Services Ltd
0.82%
ICICI Lombard General Insurance Company Ltd
0.79%
SBI Life Insurance Company Ltd
0.65%
HDFC Life Insurance Company Ltd
0.23%
Retailing
FSN E-Commerce Ventures Ltd
0.80%
Zomato Ltd
0.76%
Avenue Supermarts Ltd
0.66%
Cement & Cement Products
Nuvoco Vistas Corporation Ltd
0.58%
UltraTech Cement Ltd
0.53%
Ambuja Cements Ltd
0.45%
Power
NTPC Ltd
1.41%
Auto Components
Sona BLW Precision Forgings Ltd
1.22%
Balkrishna Industries Ltd
0.00%
Agricultural, Commercial & Construction Vehicles
Ashok Leyland Ltd
1.15%
Financial Technology (Fintech)
One 97 Communications Ltd
1.07%
Ferrous Metals
Tata Steel Ltd
0.97%
Chemicals & Petrochemicals
Vinati Organics Ltd
0.50%
Chemplast Sanmar Ltd
0.42%
Capital Markets
Indian Energy Exchange Ltd
0.84%
Healthcare Services
Krishna Institute Of Medical Sciences Ltd
0.80%
Leisure Services
Jubilant Foodworks Ltd
0.77%
Fertilizers & Agrochemicals
PI Industries Ltd
0.73%
Non - Ferrous Metals
National Aluminium Company Ltd
0.65%
Aerospace & Defense
Bharat Electronics Ltd
0.65%
Industrial Products
EPL Ltd
0.56%
Food Products
Britannia Industries Ltd
0.45%
Personal Products
Dabur India Ltd
0.30%
Equity Holding Total
99.59%
Cash & Other Receivables
0.41%
Total
100.00%

Growth of Rs. 10,000 invested at inception: 76,652

Returns (in%)
1 Yr 3 Yrs 5 Yrs SI
MALCF
-0.98%
25.44%
11.31%
14.55%
Scheme Benchmark*
-1.58%
26.66%
11.67%
10.81%
Additional Benchmark**
2.03%
27.46%
13.63%
10.89%
NAV as on 31st March, 2023 ₹ 76.652
Index Value (31st March, 2023) Index Value of Nifty 100 Index (TRI) is 22,905.08 and S&P BSE Sensex (TRI) is 89,326.31
Allotment Date 4th April, 2008
Scheme Benchmark *NIFTY 100 Index (TRI)
Additional Benchmark **S&P BSE Sensex (TRI)

Fund managers : Mr. Gaurav Khandelwal (since October 18, 2021) and Mr. Gaurav Misra (since January 31, 2019)
Note: Returns below or for 1 year are absolute returns, returns above 1 year are CAGR- Compounded Annualized Growth returns.

Past Performance may or may not be sustained in future.
Note : For computation of since inception returns (%) the allotment NAV has been taken as ₹ 10.00. The performance of other funds managed by the same fund managers are given in the respective page of the schemes
Different Plans under the scheme has different expense structure. The reference and details provided here in are of Regular Plan - Growth Option

Period Total Amount Invested Mkt Value as on
31-March-2023
SI
1,790,000
6,023,679
10 Yrs
1,200,000
2,376,594
7 Yrs
840,000
1,263,417
5 Yrs
600,000
795,905
3 Yrs
360,000
424,357
1 Yr
120,000
118,746

Returns (%)
Period
SI
10yrs
7yrs
5yrs
3yrs
1yr
Fund Return& (%)
14.89
13.11
11.47
11.26
11.00
-1.94
Benchmark Return& (%)
12.31
12.07
11.85
11.87
11.83
-3.15
Add. Benchmark Return& (%)
12.65
12.88
13.40
13.38
13.91
2.69

& The SIP returns are calculated by XIRR approach assuming investment of ₹ 10,000/- on the 1st working day of every month.

Volatility 15.62%
Beta: 0.89
R Squared 0.97
Sharpe Ratio#: 1.13
Information Ratio -0.38
Portfolio Turnover Ratio 0.22 times

@The Volatility, Beta, R Squared, Sharpe Ratio & Information Ratio are calculated on returns from last three years Monthly data points. # Risk free rate: FBIL OVERNIGHT MIBOR as on 31st March, 2023. ^Basis last rolling 12 months.

This product is suitable for investors who are seeking*
• To generate long term capital appreciation / income
• Investment predominantly in Large Cap companies

*Investors should consult their financial advisers if they are not clear about the suitability of the product.

Record Date IDCW (₹) Face Value (₹) Cum Nav (₹)
06-Dec-18
1.42 per Unit
10
18.190
16-Dec-19
1.33 per Unit
10
19.115
23-Mar-21
1.65 per Unit
10
21.616

Past Performance may or may not be sustained in future. Pursuant to payment of IDCW the NAV of the IDCW option of the scheme will fall to the extent of payout and statutory levy (if any). IDCW history is for MALCF- Regular Plan - IDCW Option